Abstract
For businesses that store physical goods, managing product inventories and financial cost accounting controls are critical. Pharmacies are under considerable scrutiny, due to the nature of their merchandise, making internal controls even more vital. Due to the emergence of COVID-19 and government mitigation strategies, the US economy has seen significant macro- and microeconomic effects. COVID-19 has changed the pharmacy working environment, which could theoretically increase rates of employee drug diversion. Therefore, better inventory management could reduce the misuse of pharmaceutical drugs from fraudulent and drug diversion activities. The author explored secondary findings to create a multidisciplinary conceptual analysis of the reasons why internal controls executed with greater diligence may be needed to avoid damaging financial, legal, and health outcomes. The author also provides a review of available internal control methods that can be used to mitigate diversion.
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference32 articles.
1. Developing Pharmacy Practice: A Focus on Patient Care;Wiedenmayer,2006
2. Accounting: Tools for Business Decision Making;Kimmel,2013
3. Inventory management in pharmacy practice;Ali;Arch. Pharm. Pract.,2011
4. The Cost of Creating a New Drug Now $5 billion, Pushing Big Pharma to Change, Forbes. Published on 11 August 2013http://www.forbes.com/sites/matthewherper/2013/08/11/how-the-staggering-cost-of-inventing-new-drugs-is-shaping-the-future-of-medicine/
5. Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献